Author:
Prestwich Robin J,Harrington Kevin J,Vile Richard G,Melcher Alan A
Reference11 articles.
1. Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial;Park;Lancet Oncol,2008
2. A smart move against cancer for vaccinia virus;Alemany;Lancet Oncol,2008
3. Progress in human tumour immunology and immunotherapy;Rosenberg;Nature,2001
4. Tolerance, danger, and the extended family;Matzinger;Annu Rev Immunol,1994
5. A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor;Hu;Clin Cancer Res,2006
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献